HCA
HCA Healthcare Inc.
$431.49
+$5.12(+1.20%)
58
Overall
65
Value
54
Tech
57
Quality
Market Cap
$104.60B
Volume
570.12K
52W Range
$330.00 - $556.52
Target Price
$517.95
Order:
Income Statement
| Metric | Trend | Chart | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec | 2025 Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||
| Total Revenue | $41.5B | $43.6B | $46.7B | $51.3B | $49.7B | $58.8B | $60.2B | $65.0B | $70.6B | $75.6B | ||
| Total Revenue | $41.5B | $43.6B | $46.7B | $51.3B | $51.5B | $58.8B | $60.2B | $65.0B | $70.6B | $75.6B | ||
| COST OF GOODS SOLD | ||||||||||||
| Cost of Revenue | $-25.8B | $-27.4B | $-29.1B | $-8.5B | $-8.4B | $9.5B | $9.4B | $9.9B | $3.3B | -- | ||
| GROSS PROFIT | ||||||||||||
| Gross Profit | $15.7B | $16.2B | $17.5B | $42.9B | $43.2B | $49.3B | $50.9B | $65.0B | $67.3B | $75.6B | ||
| OPERATING EXPENSES | ||||||||||||
| Operating Expenses | $-9.5B | $-10.2B | $-10.9B | $-35.6B | $-35.9B | $873.0M | $41.8B | $52.3B | $56.7B | $63.6B | ||
| Research & Development | -- | -- | -- | -- | -- | -- | -- | -- | $3.3B | -- | ||
| Selling, General & Administrative | -- | -- | -- | $-23.6B | $-23.9B | $9.5B | -- | $9.9B | $10.8B | $11.4B | ||
| Selling & Marketing Expenses | -- | -- | -- | -- | -- | $9.5B | -- | $9.9B | $10.8B | $11.4B | ||
| General & Administrative Expenses | -- | -- | -- | $-23.6B | $-23.9B | $400.0M | $307.0M | $353.0M | $421.0M | -- | ||
| Salaries & Wages | -- | -- | -- | $23.6B | $23.9B | $-280.0M | -- | $29.5B | $31.2B | $32.9B | ||
| Depreciation & Amortization | $2.0B | $2.1B | $2.3B | $2.6B | $2.7B | $2.9B | $3.0B | $3.1B | -- | -- | ||
| Depreciation & Amortization | $2.0B | $2.1B | $2.3B | $2.6B | $2.7B | $2.9B | -- | -- | -- | -- | ||
| Amortization | -- | -- | -- | -- | -- | $160.0M | $207.0M | $184.0M | $175.0M | -- | ||
| Other Operating Expenses | $-7.5B | $8.1B | $8.6B | $9.5B | $9.3B | $1.2B | -- | $12.9B | $14.8B | $15.9B | ||
| OPERATING INCOME | ||||||||||||
| Operating income | $6.2B | $6.1B | $6.6B | $7.2B | $7.3B | $57.9B | $59.3B | $12.7B | $10.5B | $12.0B | ||
| EBITDA | $8.5B | $8.2B | $9.4B | $9.7B | $9.7B | $62.6B | $61.3B | $12.8B | $13.9B | $15.6B | ||
| NON-OPERATING ITEMS | ||||||||||||
| Interest Expense (Non-Operating) | $1.7B | $1.7B | $1.8B | $1.8B | $1.6B | $1.6B | -- | $1.9B | $2.1B | $2.2B | ||
| Net Non-Operating Interest Income/Expense | $-1.7B | $-1.7B | $-1.8B | $-1.8B | $-1.6B | $-1.6B | $-1.7B | $-1.9B | $-2.1B | $-2.2B | ||
| Other Income/Expense | $-319.0M | $-14.0M | $-448.0M | $150.0M | $248.0M | $-1.8B | $1.3B | $3.1B | $-37.0M | $-115.0M | ||
| Other Special Charges | $-4.0M | $-39.0M | $-9.0M | $-211.0M | $-295.0M | $60.0M | -- | -- | -- | -- | ||
| SPECIAL ITEMS | ||||||||||||
| Special Income Charges | $265.0M | $-31.0M | $419.0M | $-193.0M | $-302.0M | -- | -- | -- | -- | -- | ||
| PRE-TAX INCOME | ||||||||||||
| EBIT | $6.5B | $6.1B | $7.1B | $7.1B | $7.0B | $59.7B | $58.4B | $9.6B | $10.6B | $12.1B | ||
| Pre-Tax Income | $4.8B | $4.4B | $5.3B | $5.2B | $5.4B | $58.1B | $8.6B | $7.7B | $8.5B | $9.8B | ||
| INCOME TAX | ||||||||||||
| Tax Provision | $1.4B | $1.6B | $946.0M | $1.1B | $1.0B | $-18.0M | $1.2B | $1.6B | $1.9B | $2.0B | ||
| NET INCOME | ||||||||||||
| Net Income | $2.9B | $2.2B | $3.8B | $3.5B | $3.8B | $7.7B | $5.6B | $5.2B | $5.8B | $6.8B | ||
| Net Income (Continuing Operations) | $2.9B | $2.2B | $3.8B | $3.5B | $3.8B | $58.1B | $57.1B | $6.1B | $6.7B | $7.8B | ||
| Net Income (Discontinued Operations) | $2.9B | $2.2B | $3.8B | $3.5B | $3.8B | $7.7B | $5.6B | $5.2B | $5.8B | $6.8B | ||
| Net Income (Common Stockholders) | $2.9B | $2.2B | $3.8B | $3.5B | $3.8B | $7.7B | $5.6B | $5.2B | $5.8B | $6.8B | ||
| Normalized Income | $3.2B | $2.9B | $3.9B | $4.1B | -- | -- | -- | -- | -- | $13.2B | ||
| TOTALS | ||||||||||||
| Total Expenses | $38.5B | $76.8B | $81.4B | $44.1B | $-44.3B | $10.4B | $51.2B | $52.3B | $60.1B | $63.6B | ||
| SHARE & EPS DATA | ||||||||||||
| Average Shares Outstanding | $383.6M | $362.3M | $347.3M | $341.2M | $338.3M | $323.3M | $290.3M | $272.4M | $258.6M | $236.4M | ||
| Average Shares Outstanding (Diluted) | $395.9M | $372.2M | $355.3M | $348.2M | $343.6M | $328.8M | $290.3M | $272.4M | $261.8M | $239.5M | ||
| Shares Outstanding | $370.2M | $349.9M | $342.4M | $338.4M | $339.9M | $303.6M | $277.0M | $264.5M | $248.3M | $223.6M | ||
| Basic EPS | $7.53 | $6.12 | $10.9 | $10.27 | $11.1 | $21.52 | $19.43 | $19.25 | $22.27 | $28.7 | ||
| Basic EPS (Continuing Operations) | $7.53 | -- | -- | -- | $11.1 | $21.52 | -- | -- | $22.27 | $28.7 | ||
| Diluted EPS | $7.3 | $5.95 | $10.66 | $10.07 | $10.93 | $21.16 | $19.15 | $18.97 | $22 | $28.33 | ||
| Diluted EPS (Continuing Operations) | $7.3 | -- | -- | -- | $10.93 | $21.16 | -- | -- | $22 | $28.33 | ||
| Dividend Per Share | -- | -- | $1.4 | $1.6 | $0.43 | $1.92 | $2.24 | $2.4 | $2.64 | $2.88 | ||
| OTHER METRICS | ||||||||||||
| Acquisition Expense | -- | -- | -- | -- | -- | -- | -- | -- | -- | $3.5B | ||
| Development Expense | -- | -- | -- | -- | -- | -- | -- | -- | $3.3B | -- | ||
| Earnings from equity interest | $54.0M | $45.0M | $29.0M | $43.0M | $54.0M | $113.0M | -- | $22.0M | $23.0M | $78.0M | ||
| Earnings From Equity Interest Net Of Tax | $54.0M | $45.0M | $29.0M | $43.0M | $54.0M | $113.0M | -- | $22.0M | $23.0M | $78.0M | ||
| Gain On Sale Of P P E | $23.0M | $8.0M | $428.0M | $18.0M | $-7.0M | $1.6B | -- | $-5.0M | $14.0M | $37.0M | ||
| Minority Interests | $-542.0M | $-527.0M | $-602.0M | $-640.0M | $-633.0M | $-749.0M | $-1.2B | $-849.0M | $-897.0M | $-998.0M | ||
| Net Income Extraordinary | -- | -- | -- | -- | -- | $7.7B | $6.8B | $6.1B | -- | -- | ||
| Other Gand A | -- | -- | -- | $-23.6B | $-23.9B | $400.0M | $307.0M | $353.0M | $421.0M | -- | ||
| Other Write Off | -- | -- | -- | -- | -- | -- | -- | $3.1B | -- | -- | ||
| Othspecchg | $242.0M | $-39.0M | $-9.0M | $-211.0M | $-295.0M | -- | -- | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | HCA | $431.49 | +1.2% | 570.12K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |